Graham Ross
Impact in
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 38
- HER2/EGFR in Cancer Research 20
- Lung Cancer Research Studies 14
- Peptidase Inhibition and Analysis 12
- Cancer Treatment and Pharmacology 8
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Javier CortésSandra M. SwainEmma ClarkMark BenyunesSeock‐Ah ImSung‐Bae KimYoung‐Hyuck ImTadeusz Pieńkowski
- Journals
- Journal of Clinical Oncology (20 papers)Lung Cancer (4 papers)The Lancet Oncology (3 papers)The Oncologist (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Graham Ross
42 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 8.1k
- Cancer Research 2.2k
- Radiology, Nuclear Medicine and Imaging 2.9k
- Pulmonary and Respiratory Medicine 2.2k
- Genetics 470
Countries citing papers authored by Graham Ross
This map shows the geographic impact of Graham Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Ross more than expected).
Fields of papers citing papers by Graham Ross
This network shows the impact of papers produced by Graham Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Ross. The network helps show where Graham Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside Graham Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 49 | |
| 2 | 2014 | 48 | |
| 3 | 2014 | 260 | |
| 4 | Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study Hit paper breakdown → | 2013 | 700 |
| 5 | 2013 | 43 | |
| 6 | 2013 | 106 | |
| 7 | 2013 | 19 | |
| 8 | 2012 | 16 | |
| 9 | 2012 | 182 | |
| 10 | 2012 | 6 | |
| 11 | Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Hit paper breakdown → | 2011 | 1773 |
| 12 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Hit paper breakdown → | 2011 | 1535 |
| 13 | Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy Hit paper breakdown → | 2010 | 456 |
| 14 | 2007 | 274 | |
| 15 | 2006 | 449 | |
| 16 | 2005 | 21 | |
| 17 | 2001 | 12 | |
| 18 | 1999 | 6 | |
| 19 | 1998 | 21 | |
| 20 | 1994 | 31 |
About Graham Ross
Graham Ross is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Epidemiology, Molecular Biology and Pathology and Forensic Medicine, having authored 42 papers that have together received 9.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (20 papers), Lung Cancer Research Studies (14 papers), Cancer therapeutics and mechanisms (13 papers), Peptidase Inhibition and Analysis (12 papers), Neuroendocrine Tumor Research Advances (10 papers), Cancer Treatment and Pharmacology (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Oncology (8.1k citations), Cancer Research (2.2k citations), Radiology, Nuclear Medicine and Imaging (2.9k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Genetics (470 citations). Graham Ross has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Javier Cortés, Sandra M. Swain, Emma Clark, Mark Benyunes, Seock‐Ah Im, Sung‐Bae Kim, Young‐Hyuck Im, Tadeusz Pieńkowski, José Luiz Pedrini and José Baselga. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, The Lancet Oncology, The Oncologist and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.